New WRAP Method Revolutionizes Membrane Protein Research at UW Medicine

On July 2, 2026, researchers at the University of Washington School of Medicine announced a breakthrough in membrane protein research using a novel approach called WRAP (Water-soluble Rosetta Fold-diffused Amphipathic Proteins). This innovation could significantly advance the development of therapies and vaccines targeting membrane proteins, which are crucial for cellular function.

Understanding Membrane Proteins

Membrane proteins serve as essential components of cellular structures, acting as gatekeepers for molecules entering and exiting cells. Their hydrophobic characteristics have posed challenges in biomedical research, particularly in vaccine development. David Baker, a professor at the University of Washington, noted, "Membrane proteins are notoriously difficult to work with. We needed to find a way to keep them intact in water."

Previously, scientists relied on detergents for membrane protein extraction, a method that often complicates research. The new WRAP method allows proteins to remain soluble and stable in water without using detergents, significantly simplifying the extraction process.

Breakthrough in Protein Solubilization

The research team at UW Medicine developed custom-designed proteins that encapsulate membrane proteins, effectively shielding their hydrophobic surfaces. This innovative approach enables the proteins to retain their structure while being soluble in water.

• WRAPs enable the study of membrane proteins without modifying their native sequences.
• Researchers validated the method by imaging a WRAPed Mycobacterial porin at a high resolution of 2.95 Å.
• The approach promises enhanced accessibility to membrane proteins for research and therapeutic applications.

According to Ljubica Mihaljevic, lead author of the study, “The capability provided by WRAPs opens many new possibilities for both research and therapeutic application.” This innovation may lead to advancements in vaccine development, particularly for diseases like syphilis, which has historically faced challenges due to the difficulty in studying its antigens.

Implications for Future Research

The ability to create stable, soluble antigens from membrane proteins could pave the way for new vaccines and diagnostics. The researchers highlighted the outer membrane proteins of Treponema pallidum, the bacterium responsible for syphilis, as prime candidates for future studies.

A patent application has already been filed for the new methods and proteins, indicating the potential commercial interest in this groundbreaking research. The findings were published in the journal Science, marking a significant contribution to the field of membrane protein studies.